In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Example Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Security Contractor Accountability 
Act of 2007''.

SEC. 2. LEGAL STATUS OF CONTRACT PERSONNEL.

    (a) Clarification of the Military Extraterritorial Jurisdiction 
Act.--
            (1) Inclusion of contractors.--Subsection (a) of section 
        3261 of title 18, United States Code, is amended--
                    (A) by striking ``or'' at the end of paragraph (1);
                    (B) by striking the comma at the end of paragraph 
                (2) and inserting ``; or''; and
                    (C) by inserting after paragraph (2) the following:
            ``(3) while employed under a contract (or subcontract at 
        any tier) awarded by any department or agency of the United 
        States, where the work under such contract is carried out in an 
        area, or in close proximity to an area (as designated by the 
        Department of Defense), where the Armed Forces is conducting a 
        contingency operation,''.
            (2) Definition.--Section 3267 of title 18, United States 
        Code, is amended by adding at the end the following:
            ``(5) The term `contingency operation' has the meaning 
        given such term in section 101(a)(13) of title 10.''.
    (b) Department of Justice Inspector General Report.--
            (1) Report required.--Not later than 180 days after the 
        date of the enactment of this Act, the Inspector General of the 
        Department of Justice shall submit to Congress a report in 
        accordance with this subsection.
            (2) Content of report.--The report under paragraph (1) 
        shall include--
                    (A) a description of the status of Department of 
                Justice investigations of alleged violations of section 
                3261 of title 18, United States Code, to have been 
                committed by contract personnel, which shall include--
                            (i) the number of complaints received by 
                        the Department of Justice;
                            (ii) the number of investigations into 
                        complaints opened by the Department of Justice;
                            (iii) the number of criminal cases opened 
                        by the Department of Justice; and
                            (iv) the number and result of criminal 
                        cases closed by the Department of Justice; and
                    (B) findings and recommendations about the number 
                of criminal cases prosecuted by the Department of 
                Justice involving violations of section 3261 of title 
                18, United States Code.
            (3) Format of report.--The report under paragraph (1) shall 
        be submitted in unclassified format, but may contain a 
        classified annex as appropriate.

SEC. 3. FEDERAL BUREAU OF INVESTIGATION INVESTIGATIVE UNIT FOR 
              CONTINGENCY OPERATIONS.

    (a) Establishment of Theater Investigative Unit.--The Director of 
the Federal Bureau of Investigation shall ensure that there are 
adequate personnel through the creation of Theater Investigative Units 
to investigate allegations of criminal violations of section 3261 of 
title 18, United States Code, by contract personnel.
    (b) Responsibilities of Theater Investigative Unit.--The Theater 
Investigative Unit established for a theater of operations shall--
            (1) investigate reports that raise reasonable suspicion of 
        criminal misconduct by contract personnel;
            (2) investigate reports of fatalities resulting from the 
        use of force by contract personnel; and
            (3) upon conclusion of an investigation of alleged criminal 
        misconduct, refer the case to the Attorney General of the 
        United States for further action, as appropriate in the 
        discretion of the Attorney General.
    (c) Responsibilities of Federal Bureau of Investigation.--
            (1) Resources.--The Director of the Federal Bureau of 
        Investigation shall ensure that each Theater Investigative Unit 
        has adequate resources and personnel to carry out its 
        responsibilities.
            (2) Notification.--The Director of the Federal Bureau of 
        Investigation shall notify Congress whenever a Theater 
        Investigative Unit is established or terminated in accordance 
        with this section.
    (d) Responsibilities of Other Federal Agencies.--An agency 
operating in an area, or in close proximity to an area (as designated 
by the Department of Defense), where the Armed Forces is conducting a 
contingency operation shall cooperate with and support the activities 
of the Theater Investigative Unit. Any investigation carried out by the 
Inspector General of an agency shall be coordinated with the activities 
of the Theater Investigative Unit as appropriate.

SEC. 4. DEFINITIONS.

    In this Act:
            (1) Covered contract.--The term ``covered contract'' means 
        an agreement--
                    (A) that is--
                            (i) a prime contract awarded by an agency;
                            (ii) a subcontract at any tier under any 
                        prime contract awarded by an agency; or
                            (iii) a task order issued under a task or 
                        delivery order contract entered into by an 
                        agency; and
                    (B) according to which the work under such 
                contract, subcontract, or task order is carried out in 
                a region outside the United States in which the Armed 
                Forces are conducting a contingency operation.
            (2) Agency.--The term ``agency'' has the meaning given the 
        term ``Executive agency'' in section 105 of title 5, United 
        States Code.
            (3) Contingency operation.--The term ``contingency 
        operation'' has the meaning given the term section 101(13) of 
        title 10, United States Code.
            (4) Contractor.--The term ``contractor'' means an entity 
        performing a covered contract.
            (5) Contract personnel.--The term ``contract personnel'' 
        means persons assigned by a contractor (including 
        subcontractors at any tier) to perform work under a covered 
        contract.

SEC. 5. EFFECTIVE DATE.

    (a) Applicability.--The provisions of this Act shall apply to all 
covered contracts and all covered contract personnel in which the work 
under the contract is carried out in an area, or in close proximity to 
an area (as designated by the Department of Defense), where the Armed 
Forces is conducting a contingency operation on or after the date of 
the enactment of this Act.
    (b) Immediate Effectiveness.--The provisions of this Act shall 
enter into effect immediately upon the enactment of this Act.
    (c) Implementation.--With respect to covered contracts and covered 
contract personnel discussed in subsection (a)(1), the Director of the 
Federal Bureau of Investigation, and the head of any other agency to 
which this Act applies, shall have 90 days after the date of the 
enactment of this Act to ensure compliance with the provisions of this 
Act.
Example Output: Security Contractor Accountability Act of 2007 - Provides that persons who, while employed under a federal agency contract in or in close proximity to an area where the Armed Forces are conducting a contingency operation, engage in conduct that would constitute an offense punishable by imprisonment for more than one year if engaged in within U.S. jurisdiction shall be punished as provided for that offense.

Requires the Inspector General of the Department of Justice (DOJ) to report to Congress on the status of the Department's investigations of violations alleged to have been committed by contract personnel and findings and recommendations about the Department's capacity and effectiveness in prosecuting misconduct by contract personnel.

Requires the Director of the Federal Bureau of Investigation (FBI) to ensure, through the creation of Theater Investigative Units, that there are adequate personnel to investigate allegations of criminal violations by contract personnel.

Example Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Prescription Drug Fairness for 
Seniors Act of 2001''.

SEC. 2. FINDINGS AND PURPOSES.

    (a) Findings.--The Congress finds the following:
            (1) Manufacturers of prescription drugs engage in price 
        discrimination practices that compel many older Americans to 
        pay substantially more for prescription drugs than consumers in 
        foreign nations and the drug manufacturers' most favored U.S. 
        customers, such as health insurers, health maintenance 
        organizations, and the Federal Government.
            (2) Older Americans who buy their own prescription drugs 
        often pay twice as much for prescription drugs as consumers in 
        foreign nations and the drug manufacturers' most favored U.S. 
        customers. In some cases, older Americans pay 10 times more for 
        prescription drugs than such customers.
            (3) The discriminatory pricing by major drug manufacturers 
        sustains their high profits (for example, $27,300,000,000 in 
        1999), but causes financial hardship and impairs the health and 
        well-being of millions of older Americans. Many older Americans 
        are forced to choose between buying their food and buying their 
        medicines.
            (4) Foreign nations and U.S. federally funded health care 
        programs use purchasing power to obtain prescription drugs at 
        low prices. Medicare beneficiaries are denied this benefit and 
        cannot obtain their prescription drugs at the lower prices 
        available to such nations and programs.
            (5) Implementation of the policy set forth in this Act will 
        reduce prices for brand name prescription drugs for many 
        Medicare beneficiaries by an average of 40 percent.
            (6) In addition to substantially lowering the costs of 
        prescription drugs for older Americans, implementation of the 
        policy set forth in this Act will significantly improve the 
        health and well-being of older Americans and lower the costs to 
        the Federal taxpayer of the Medicare program.
            (7) Older Americans who are terminally ill and receiving 
        hospice care services represent some of the most vulnerable 
        individuals in our nation. Making prescription drugs available 
        to Medicare beneficiaries under the care of Medicare-certified 
        hospices will assist in extending the benefits of lower 
        prescription drug prices to those most vulnerable and in need.
    (b) Purpose.--The purpose of this Act is to protect Medicare 
beneficiaries from discriminatory pricing by drug manufacturers and to 
make prescription drugs available to Medicare beneficiaries at 
substantially reduced prices.

SEC. 3. PARTICIPATING MANUFACTURERS.

    (a) In General.--Each participating manufacturer of a covered 
outpatient drug shall make available for purchase by each pharmacy such 
covered outpatient drug in the amount described in subsection (b) at 
the price described in subsection (c).
    (b) Description of Amount of Drugs.--The amount of a covered 
outpatient drug that a participating manufacturer shall make available 
for purchase by a pharmacy is an amount equal to the aggregate amount 
of the covered outpatient drug sold or distributed by the pharmacy to 
Medicare beneficiaries.
    (c) Description of Price.--The price at which a participating 
manufacturer shall make a covered outpatient drug available for 
purchase by a pharmacy is a price no greater than the manufacturer's 
average foreign price.
    (d) Enforcement.--The United States shall debar a manufacturer of 
drugs or biologicals that does not comply with the provisions of this 
Act.

SEC. 4. SPECIAL PROVISION WITH RESPECT TO HOSPICE PROGRAMS.

    For purposes of determining the amount of a covered outpatient drug 
that a participating manufacturer shall make available for purchase by 
a pharmacy under section 3, there shall be included in the calculation 
of such amount the amount of the covered outpatient drug sold or 
distributed by a pharmacy to a hospice program. In calculating such 
amount, only amounts of the covered outpatient drug furnished to a 
Medicare beneficiary enrolled in the hospice program shall be included.

SEC. 5. ADMINISTRATION.

    The Secretary shall issue such regulations as may be necessary to 
implement this Act.

SEC. 6. REPORTS TO CONGRESS REGARDING EFFECTIVENESS OF ACT.

    (a) In General.--Not later than 2 years after the date of the 
enactment of this Act, and annually thereafter, the Secretary shall 
report to the Congress regarding the effectiveness of this Act in--
            (1) protecting Medicare beneficiaries from discriminatory 
        pricing by drug manufacturers, and
            (2) making prescription drugs available to Medicare 
        beneficiaries at substantially reduced prices.
    (b) Consultation.--In preparing such reports, the Secretary shall 
consult with public health experts, affected industries, organizations 
representing consumers and older Americans, and other interested 
persons.
    (c) Recommendations.--The Secretary shall include in such reports 
any recommendations the Secretary considers appropriate for changes in 
this Act to further reduce the cost of covered outpatient drugs to 
Medicare beneficiaries.

SEC. 7. DEFINITIONS.

    In this Act:
            (1) Average foreign price.--
                    (A) In general.--The term ``average foreign price'' 
                means, with respect to a covered outpatient drug, the 
                average price that the manufacturer of the drug 
                realizes on the sale of drugs with the same active 
                ingredient or ingredients that are consumed in covered 
                foreign nations, taking into account--
                            (i) any rebate, contract term or condition, 
                        or other arrangement (whether with the 
                        purchaser or other persons) that has the effect 
                        of reducing the amount realized by the 
                        manufacturer on the sale of the drugs; and
                            (ii) adjustments for any differences in 
                        dosage, formulation, or other relevant 
                        characteristics of the drugs.
                    (B) Exempt transactions.--The Secretary may, by 
                regulation, exempt from the calculation of the average 
                foreign price of a drug those prices realized by a 
                manufacturer in transactions that are entered into for 
                charitable purposes, for research purposes, or under 
                other unusual circumstances, if the Secretary 
                determines that the exemption is in the public interest 
                and is consistent with the purposes of this Act.
            (2) Covered foreign nation.--The term ``covered foreign 
        nation' means Canada, France, Germany, Italy, Japan, and the 
        United Kingdom.
            (3) Covered outpatient drug.--The term ``covered outpatient 
        drug'' has the meaning given that term in section 1927(k)(2) of 
        the Social Security Act (42 U.S.C. 1396r-8(k)(2)).
            (4) Debar.--The term ``debar'' means to exclude, pursuant 
        to established administrative procedures, from Government 
        contracting and subcontracting for a specified period of time 
        commensurate with the seriousness of the failure or offense or 
        the inadequacy of performance.
            (5) Hospice program.--The term ``hospice program'' has the 
        meaning given that term under section 1861(dd)(2) of the Social 
        Security Act (42 U.S.C. 1395x(dd)(2)).
            (6) Medicare beneficiary.--The term ``Medicare 
        beneficiary'' means an individual entitled to benefits under 
        part A of title XVIII of the Social Security Act or enrolled 
        under part B of such title, or both.
            (7) Participating manufacturer.--The term ``participating 
        manufacturer'' means any manufacturer of drugs or biologicals 
        that, on or after the date of the enactment of this Act, enters 
        into a contract or agreement with the United States for the 
        sale or distribution of covered outpatient drugs to the United 
        States.
            (8) Secretary.--The term ``Secretary'' means the Secretary 
        of Health and Human Services.

SEC. 8. EFFECTIVE DATE.

    The Secretary shall implement this Act as expeditiously as 
practicable and in a manner consistent with the obligations of the 
United States.
Example Output: Prescription Drug Fairness for Seniors Act of 2001 - Requires each participating manufacturer of a covered outpatient drug to make it available for purchase by each pharmacy: (1) in an amount equal to the aggregate amount sold or distributed by the pharmacy to Medicare beneficiaries; and (2) at a price no greater than the manufacturer's average foreign price. Sets forth special provisions with respect to hospice programs.

Example Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Social Security Benefits Protection 
and Restoration Act of 1997''.

SEC. 2. FINDINGS AND PURPOSES.

    (a) Initial Findings.--The Congress finds the following:
            (1) Over the last 5 decades, billions of dollars in social 
        security taxes have been paid by American workers but have not 
        been credited to their social security earnings records. When 
        the Social Security Administration is not able to match 
        information on annual earnings reports to existing workers' 
        earnings records, the amount of such earnings reported are 
        credited by the Administration in a ``suspense file'' of 
        uncredited earnings.
            (2) Largely due to the inflexible matching policy of the 
        Social Security Administration and an unacceptable number of 
        errors made by employers on annual earnings reports submitted 
        to the Administration, the suspense file has accumulated 
        approximately 200,000,000 individual earnings reports totaling 
        approximately $200,000,000,000 in earnings. These numbers 
        continue to grow.
            (3) Because earnings are used to determine an individual's 
        eligibility and benefit amount, uncredited earnings can affect 
        social security benefit payments. Current beneficiaries have 
        lost, and continue to lose, benefits because of the failure of 
        the Social Security Administration to correctly credit their 
        earnings. This has the practical effect of denying millions of 
        hard-working Americans up to hundreds of dollars on their 
        monthly retirement or disability benefits.
    (b) Further Findings.--The Congress further finds the following:
            (1) Current and future retirees should receive the full 
        social security benefits to which they are entitled.
            (2) The impact of uncredited earnings on social security 
        beneficiaries has not been adequately determined. An 
        examination of the practical effects of uncredited earnings on 
        individuals' benefits should be conducted, in order that 
        beneficiaries who are due higher benefits or retroactive 
        payments can be compensated accordingly.
    (c) Purpose.--It is the purpose of this Act to ensure that the 
Social Security Administration, together with the Secretary of the 
Treasury, will take prompt action to--
            (1) determine and implement an effective procedure to 
        reconcile the wage reports currently in the suspense file to 
        the rightful beneficiaries, and
            (2) put in place a system that will prevent further 
        mismatches.

SEC. 3. STUDY.

    (a) In General.--The Commissioner of Social Security and the 
Secretary of the Treasury shall jointly undertake, as soon as 
practicable after the date of the enactment of this Act, a thorough 
study with respect to the inability of the Social Security 
Administration to provide for American workers their full social 
security benefits by reason of insufficiency of information held by the 
Administration necessary for correctly identifying accounts for the 
earnings of such workers.
    (b) Matters To Be Studied.--The Commissioner and the Secretary, in 
their study under this section, shall address, analyze, and report 
specifically on the following matters:
            (1) the extent of, and the reasons for, the inability of 
        the Social Security Administration to maintain accurate and 
        current records of every worker's annual earnings sufficient 
        for determining eligibility for, and the correct amount of, 
        monthly insurance benefits under title II of the Social 
        Security Act,
            (2) proposals for an effective procedure for eliminating 
        the current backlog of uncredited earnings in the suspense file 
        maintained by the Social Security Administration,
            (3) proposals for an effective procedure for resolving new 
        discrepancies which would result in new uncredited earnings, 
        and
            (4) any additional resources which the Social Security 
        Administration would require to carry out effective procedures 
        described in paragraphs (2) and (3).

SEC. 4. REMEDIAL MEASURES.

    Pursuant to the study carried out under section 3, the Commissioner 
of Social Security and the Secretary of the Treasury shall promptly--
            (1) devise and implement a procedure for eliminating, in 
        accordance with an established time-phased schedule, the 
        backlog of uncredited earnings currently contained in the 
        suspense file maintained by the Administration, and
            (2) devise and implement a procedure for resolving new 
        discrepancies which would prevent the addition of future 
        uncredited earnings in the suspense file.

SEC. 5. REPORT.

    The Commissioner of Social Security and the Secretary of the 
Treasury shall submit to the Committee on Ways and Means of the House 
of Representatives and the Committee on Finance of the Senate, not 
later than 180 days after the date of the enactment of this Act, a 
report of the findings of the study conducted under section 3 and the 
progress made in meeting the requirements of section 4. Such report 
shall include any recommendations for further legislative action the 
Commissioner and the Secretary consider appropriate.
Example Output:
Social Security Benefits Protection and Restoration Act of 1997 - Directs the Commissioner of Social Security and the Secretary of the Treasury to:  (1) study jointly and report to the Congress on the inability of the Social Security Administration to provide American workers with their full social security benefits because of insufficient information necessary to identify account earnings information correctly for such workers at the Administration; (2) take appropriate remedial measures, including devising and implementing a procedure for eliminating backlogged uncredited earnings filed with the Administration.  Requires a progress report to the Congress on implementation of such measures, along with any recommendations for appropriate legislative action.